NEE
38
-6
BRK.B
36
-6
XYL
25
2
HPE
35
12
TDC
39
-2
ABBV
37
-3
SCHW
61
-3
VFC
30
-4
PAYX
50
-3
HSIC
44
-3
COF
53
-2
OMC
32
-8
VRSN
44
-3
URBN
59
9
ORCL
46
-3
EIX
40
-2
PRGO
25
3
PPG
33
-2
EOG
37
3
NEM
59
2
NEE
38
-6
BRK.B
36
-6
XYL
25
2
HPE
35
12
TDC
39
-2
ABBV
37
-3
SCHW
61
-3
VFC
30
-4
PAYX
50
-3
HSIC
44
-3
COF
53
-2
OMC
32
-8
VRSN
44
-3
URBN
59
9
ORCL
46
-3
EIX
40
-2
PRGO
25
3
PPG
33
-2
EOG
37
3
NEM
59
2
Financhill
Back

Regenxbio Stock Predictions

Market's down 10% YTD Buffet's Berkshire up 13%

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

RGNX
Regenxbio

Last Price:
$5.95
Seasonality Move:
10.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Regenxbio Stock Forecast

  • Over the next 52 weeks, Regenxbio has on average historically risen by 11.4% based on the past 9 years of stock performance.
  • Regenxbio has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Regenxbio Stock Undervalued?
    The current Regenxbio [RGNX] share price is $6.16. The Score for RGNX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Regenxbio Stock Go Up Next Year?

  • Over the next 52 weeks, Regenxbio has on average historically risen by 11.4% based on the past 9 years of stock performance.

Regenxbio Stock Rating

Sell
17
Regenxbio (RGNX) is a Sell

Is Regenxbio overpriced?

  • Regenxbio has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Regenxbio Stock Price History

Is RGNX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regenxbio.com

52-Week Data

52-Week High:
17.99
52-Week Low:
5.04

Prediction Charts

Market Cap:
308.5M
Price in USD:
6.16
Volume:
699.7K
Beta:
1.14

Technical Analysis

SMA50:
7.07
SMA100:
7.73
SMA200:
9.56
52-Wk Change:
-64.8%

Stock Predictions

  • Is Regenxbio stock public?
    Yes, Regenxbio is a publicly traded company.
  • What is the Regenxbio stock quote today?
    The Regenxbio stock price is 6.16 USD today.
  • How to buy Regenxbio stock online?
    You can buy Regenxbio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-28 7.90 7.83 7.96 7.68
Mar-31 7.45 7.15 7.46 6.77
Apr-1 7.18 6.76 7.18 6.61
Apr-2 6.63 7.05 7.25 6.57
Apr-3 6.55 6.67 6.74 6.45
Apr-4 6.45 6.29 6.55 6.26
Apr-7 5.86 5.93 6.16 5.51
Apr-8 6.08 5.31 6.27 5.25
Apr-9 5.24 5.91 6.02 5.04
Apr-10 5.71 5.41 5.77 5.15
Apr-11 5.43 5.89 5.95 5.15
Apr-14 6.02 6.33 6.36 5.81
Apr-15 6.31 6.55 6.83 6.20
Apr-16 6.39 6.16 6.47 6.06

Regenxbio Earnings

Regenxbio Earnings Report: Per Share Regenxbio Earnings Q1 Q2 Q3 and Q4 last year and next year.

Regenxbio Forecast Revenue Growth

Regenxbio Stock Analysis: Historical quarterly revenues per share for Regenxbio and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.78 per share, and an increase next year of $0.26 per share.

* Regenxbio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.